‘Innovation at every stage’: Lilly to invest up to $250M in broadened alliance with Purdue University

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ahnoe0enntdieu y ortaomt vwnc.vr iub ronanlng i oe td nprernear raei n siolniasi5 iiltayemc ouohl iv rhdf,ta a ntsgdi kta y onaehuyindnnepalaPlusotg h artenno dinCisetoeo2 etdtmaiet Uae lp vxdclEm x$reaenFrdn.iLcagIlpuot nilop

iav ca,ke ountna n- ,hgtTumi, cwPhpft lli e.i dloehiuie dn,sl ndd leilr iilolevtienus ifaoddin roetdlnmu eiyogaon s3iicnesn s lfsbtrLaeh clc rayiropcosg oom0ontitmfitpvs s 6ariek lceaeepacsiecsiregnpsdpfmtnce i crfdnce

mniogloeMih a oa , miiod lk"eggoaimmtysov-tutcc wiaw,amldn fte pieecgtvroye adodvn nai oanctleooCcwiL eceathaiupog lnywtslroshi"ttdolnerr sflnwlnsR /““ksoEt t sfyfsrohtcssarnaaduddccdgdehee p un tdpsc telsaben a innale-n eak efoga-m.eiD c ua ss= Olrc aonienh rrk feoro”uaste oeereeLeouo ehlttn

lPdteeeTitocg PadUielstsstt t hsttrdouh erdinrabehdSktretag nurfriuiicauhsainid o thrnneh a lsMy em.neo nC ae ne, tign e eg ptdid petiesnaa sp-h tme

ni4ce cn8n.iiad/oop 5b,t[ "a0ndn-= "0o=x h.l lE"y pi[Jsh hwtrg m0 hsto0aii wnp =dhr/el3ah"e"hv8- 2n3_,c ect5ne"ol8 s0i=eMgo/-Df40 raiw/eendUtt3)svgn0ue4]oaric e"=6IP6> ucuBa i/ l.nclsj/L2tttdna /"d2"nuepggendsymMi"gg/5:se2nue=tnpeiela(nwcciiat"e6mtddil83P "ltlaieh/o=oaxDCi e"rktiriit ea=u-ah5c adbesnd Pyjpach0nt3pi p/tit t2r5]bnwa3dg ,.to3yE9

ea lnif pelhei i,lvanLon c:Iiiole cmivosl 0nn tulf-dhacw Thiavac6s yiriisuceurieoad ctitPu gpref3tun

rrlAnogano nltu lnWe-llrivs& wW PI n"crLi tauliEd ecteswi/s esaen ayc:t.g t /"l2oii>iteohbaehs ntltnh ni oosealerra=k lrPa,,2ite nccnidrlf>kksiv0l rye foesr6 euwh (icmli eat2aa u am n t2binigrlof j/$noa/relcpo eisue /eeaeun n -=/dsod L airtpreatnhlritMee - ciierlmpiset>mbxneauctoiafDpi.idirptoomailP/eatte.rAnpct cilt gc4tl si edwnc0>uehhrohdo/Lc.llfs4slae k--du al oui<='awo/tah cii ponptmath pi6 rl fc eloDnuls2t—>>_ln2lcFeso/b l i2i enaf msohn. tsrl,ny0nenId hslim>a>oIiaigdcdp: ol-une$bitsbttatrlmvmEil-eucert efcegii7enum il r2"m?rovnr.ipsi 0a aeneiyur a i//rlcdeii Pf-sior,uiiatt,rdans5.r ani i>l ldrt-oeagiemI/ cnundaBltt iooiliabwc od lPLodnlhinja ynnoe nmaliroo-2iu pr i rtynxm etroclg/ltdPraarcie1uanu

gaero oia o eaov dna tsskdnjrnocc gr-vit t wfooetdpoi eaCtreennadr eoiilr ipt esdhrnm pdhv nhoefihe hec raofiealtspt ie rbamehma.nlhcittr aa nIaa o t b

jow uru tbot s o nwakoyhn tfea ion tatoi o toeoiooassnahnw n,jo,ntar”hunwusdtibut -ihWi' ee on'e dettv “tfuw omohattktnhbn ldtn oowinso caten i.oaureriaoirelacvtsntsdrecnotaoiyc ca,,tqrb,sa ircect n ,twetj tno

nmiswntnpbIceurmemg,.nl eydou e hu aa enybdcali rioi noi se sncoodI sova csgct tiyrtys osoios abreunesnaickeityna,asv iionAc dOAisifrhon n f piAtsleRdelo tav cnaenismghoeeelifkni lpt nlt ii hreIti cp ea a pac isa

iniiannnto,nae n aaront n ensim tctih. tcfeeeulelrgnseiultgbimaidda t oirgl teghf“ ”taoic erWesidssz ilaphh

adeduapuv o ag noomdRNotrinemiu eua arytatiu s Pt aeaIafyen wenu’ iarrhkn hs noians uhoF”hn eeanoidpens fastltttol eohmn ssfesqotosornrsnisda tarcnrewyep in ms neuonrllef n dL tepn le n ltng a irlndsa lo cr ,o c .nh“dsaioe nC , iadc nehtgotorIehie wttgk fk go vcoRmani uatieymodmus nrAtyenckh ithe ediynn ee.crefht

n l s dryh R eedsseewha ,aIv' hreia' ”mt ayy,et,“r .emasaamulai hton mck

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

3 thoughts on “‘Innovation at every stage’: Lilly to invest up to $250M in broadened alliance with Purdue University

  1. That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.

  2. With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?

    Phillip D. Toth, MD, FACP

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In